Asklepios Fortesp. j.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-04-22
Registered address
Pocztowa 1/1, 89-500 Tuchola, Poland
Electronic delivery address
AE:PL-87718-38775-SIVSV-19

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 72 days early.

  • 202527/05/2026
  • 202415/06/2025
  • 202320/06/2024
  • 202223/06/2023
  • 202101/04/2022
  • 202029/03/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 17%
Division · Retail trade1,386 / 9,914
Top 14%
City · Tuchola7 / 47
Top 15%
Voivodeship · Kujawsko-Pomorskie1,028 / 11,480
Top 8.9%
Country · Poland24,347 / 297,873
Top 8.2%

Results vs industry

Revenue
This companyUSD 7.40mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 413.04kMedianUSD 20.70kAverageUSD 86.94k
Operating costs
This companyUSD 6.94mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 2.98mMedianUSD 543.65kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Asklepios Forte has been an NFZ healthcare provider since 2026. In 2026 it is performing 1 contract worth USD 0.00.

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmacieskujawsko-pomorskie1USD 0.00

Ownership

Manner of representation

Each partner has the right to represent the company.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1995-03-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $205,448.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5,765
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$186.9K
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5,717

Competitors

Name
MybestpharmS.A.
Fragalsp. z o.o.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.

Change history

DateEvent
2024-08-30Name change
2008-03-20Name change
2006-09-07Name change
2002-04-22Entered in the register

FAQ

Last updated: 2026-05-27